Breathe Well Live Well
|
OPD: Missing teen has asthma, ran away without medication
Ocala Around 10 p.m. Wednesday, the father of Jason “Jose” Escandon-Zafrin found a note left behind by his son stating he was leaving. The father told police he is concerned about Jose, who has asthma and left without his medication. Officials said the teen … |
View full post on asthma – Google News
Telegraph.co.uk |
22000 asthma sufferers prescribed potentially deadly medication
Telegraph.co.uk Asthma UK has discovered that 22,000 people, including 2,000 children, are currently carrying inhalers which although keep their airways open do not treat the underlying inflammation, and actually leave them even more exposed to pollen and pollution. Doctors putting 100000 UK asthma sufferers in danger, says charity Asthma Sufferers May Be At Risk Of Taking Deadly Medication Thousands of asthma-sufferers at risk of potentially life-threatening attacks … |
View full post on asthma – Google News
The Inquisitr |
Asthma Sufferers May Be At Risk Of Taking Deadly Medication
The Inquisitr Nearly 5.4 million Britons have the chronic lung disease, asthma. That's more people with asthma than in any other European country. Asthma kills nearly 1,250 people a year in the UK, including sufferers who do not have a severe form of the chronic … Doctors putting 100000 UK asthma sufferers in danger, says charity 22000 asthma sufferers prescribed potentially deadly medication Thousands of asthma-sufferers at risk of potentially life-threatening attacks … |
View full post on asthma – Google News
Medical Marketing and Media |
GSK asthma medication to go before FDA panel Thursday
Medical Marketing and Media GSK's struggle is tied to its blockbuster asthma drug Advair. The drugmaker not only had to lower the price of the branded medication before generic competition surfaced, but it has also failed to build a market for its successor line of Ellipta-based … |
View full post on asthma – Google News
The Pharmaceutical Journal |
Pharmacists Can Correct Asthma Controller Medication Underuse
Pharmacy Times A study published May 4, 2015 in Pediatrics analyzed data from 35,467 asthma medication prescriptions filled between January 31, 2010, and January 30, 2012, for children aged 2 to 17 years in Hamilton County, Ohio. Classifying the asthma medications as … Pharmacies could play a role in reducing asthma-related deaths |
View full post on asthma – Google News
|
Neuropsychiatric events linked to asthma medication
AAP News (subscription) Montelukast is approved to treat asthma and symptoms of allergic rhinitis and to prevent exercise-induced asthma. Warnings regarding increased risk of neuropsychiatric events were added to the product label for montelukast and other leukotriene … |
View full post on asthma – Google News
HCPLive |
Adherence for Pediatric Asthma Medication Improved with Phone Call Reminders
HCPLive Researchers from Kaiser Permamente examined nearly 1,200 children aged 3 to 12 years for 24 months in order to test a SR intervention to improve adherence to pediatric asthma controller medication. The participants had persistent asthma diagnosis and … |
View full post on asthma – Google News
HIT Consultant |
Medicaid Health Plan Offers Personalized Medication Adherence Platform for …
HIT Consultant AmeriHealth D.C., the largest Medicaid managed care organization in the District announced it will offer its members a personalized digital mobile platform aimed at improving medication adherence for asthma patients. The platform called HealthNHandSM … |
View full post on asthma – Google News
Sydney Morning Herald |
Popular asthma medication combination could be fatal for children
Sydney Morning Herald Too many asthmatic children are being prescribed a potent mix of medications that can be life-threatening, a leading paediatrician has warned. Peter van Asperen, professor of paediatric respiratory medicine at Sydney University, said GPs are … Australian doctors overprescribing combination of asthma medications, putting … Research shows doctors over prescribing potentially dangerous asthma … A fatal, laissez-faire link to treating asthma in children |
View full post on asthma – Google News
| Related Articles |
Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions.
Am J Health Syst Pharm. 2015 Feb 1;72(3):198-202
Authors: Jones JM, Richter LM, Alonto A, Leedahl DD
Abstract
PURPOSE: The case of a patient with multiple medication hypersensitivity reactions and a methicillin-resistant Staphylococcus aureus (MRSA) infection who underwent desensitization to ceftaroline is reported.
SUMMARY: A 32-year-old Caucasian woman with asthma, gastroesophageal reflux disease, heart murmur, and major depression was admitted for MRSA cellulitis with a subcutaneous abscess along the left sternomanubrial joint and clavicular osteomyelitis secondary to port placement after gastric bypass surgery. The patient had an extensive history of hypersensitivity reactions. Pertinent documented allergies were as follows: penicillin (anaphylaxis), daptomycin (anaphylaxis), vancomycin (hives), linezolid (hives), ertapenem (rash), ciprofloxacin (rash), and tigecycline (rash). The patient also reported previous reactions to aztreonam (unknown) and gentamicin (hives). The pharmacy was consulted to develop a desensitization protocol for ceftaroline. The desensitization protocol used three serial dilutions of ceftaroline to make 14 sequential infusions with escalating doses. Intramuscular epinephrine, i.v. diphenhydramine, and i.v. methylprednisolone were ordered as needed for the development of immediate hypersensitivity reactions during or after administration of ceftaroline. The cumulative dose (574.94 mg) was administered intravenously over 225 minutes with no breakthrough symptoms reported during or after the desensitization protocol. Ceftaroline fosamil 600 mg i.v. every 12 hours was continued for six weeks.
CONCLUSION: Desensitization to ceftaroline was conducted for a patient with extensive history of hypersensitivity reactions to other drugs, including penicillin-induced anaphylaxis. Desensitization and subsequent treatment with full doses of ceftaroline were accomplished without apparent adverse effects.
PMID: 25596602 [PubMed – in process]
View full post on pubmed: asthma